| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CEO, Pss Segment | CEO, Pharmaceutical Segment
1 company
Weitzman Deborah is a CEO, Pss Segment at CARDINAL HEALTH INC. Recent SEC Form 4 filings include 0 buys and 3 sells.
Estimated insider holdings value: $9.9M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 20, 2025 | CAH Cardinal Health Inc | CEO, Pss Segment | Sell | 21,367 | $150.53 | $3,216,374.51 | -28.6% | +35.3% | - | |
| Nov 27, 2023 | CAH Cardinal Health Inc | CEO, Pharmaceutical Segment | Sale+OE | 36,642 | $106.31 | $3,895,411.02 | -51.0% | +3.4% | +14.8% | |
| Aug 28, 2023 | CAH Cardinal Health Inc | CEO, Pharmaceutical Segment | Sale+OE | 6,712 | $89.81 | $602,804.72 | -13.2% | +18.8% | +22.7% |